...
首页> 外文期刊>Current infectious disease reports. >Empiric Antimicrobial Therapy in Severe Sepsis and Septic Shock: Optimizing Pathogen Clearance
【24h】

Empiric Antimicrobial Therapy in Severe Sepsis and Septic Shock: Optimizing Pathogen Clearance

机译:严重脓毒症和感染性休克的经验性抗菌疗法:优化病原体清除率

获取原文
获取原文并翻译 | 示例
           

摘要

Mortality and morbidity in severe sepsis and septic shock remain high despite significant advances in critical care. Efforts to improve outcome in septic conditions have focused on targeted, quantitative resuscitation strategies utilizing intravenous fluids, vasopressors, inotropes, and blood transfusions to correct disease-associated circulatory dysfunction driven by immune-mediated systemic inflammation. This review explores an alternate paradigm of septic shock in which microbi-al burden is identified as the key driver of mortality and progression to irreversible shock. We propose that clinical outcomes in severe sepsis and septic shock hinge upon the optimized selection, dosing, and delivery of highly potent antimicrobial therapy.
机译:尽管重症监护取得了重大进展,但严重败血症和败血性休克的死亡率和发病率仍然很高。在脓毒症中改善结局的努力集中在利用静脉输液,升压药,正性肌力药物和输血来纠正由免疫介导的全身性炎症驱动的疾病相关循环功能障碍的靶向,定量复苏策略。这篇评论探讨了败血性休克的另一种范式,其中微生物负荷被确定为死亡率和不可逆性休克发展的关键驱动力。我们建议严重败血症和败血性休克的临床结果取决于优化的高效抗菌治疗的选择,给药和给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号